Vareniklin Testmiljö
Vareniklin
Klass : 2
Visa all info
Skriv ut
Kontakta oss
Kallen K. The impact of maternal smoking during pregnancy on delivery outcome. Eur J Public Health 2001;11:329-33.
Abraham M, Alramadhan S, Iniguez C, Duijts L, Jaddoe VW, Den Dekker HT et al. A systematic review of maternal smoking during pregnancy and fetal measurements with meta-analysis. PLoS One. 2017;12(2):e0170946.
Jaddoe VW, Verburg BO, de Ridder MA, Hofman A, Mackenbach JP, Moll HA et al. Maternal smoking and fetal growth characteristics in different periods of pregnancy: the generation R study. Am J Epidemiol. 2007;165(10):1207-15.
Tatiana M Anderson, Juan M Lavista Ferres, Shirley You Ren, Rachel Y Moon, Richard D Goldstein, Jan-Marino Ramirez, Edwin A Mitchell. Maternal Smoking Before and During Pregnancy and the Risk of Sudden Unexpected Infant Death. Pediatrics. 2019;143(4):e20183325.
Vardavas CI, Hohmann C, Patelarou E, Martinez D, Henderson AJ, Granell R et al. The independent role of prenatal and postnatal exposure to active and passive smoking on the development of early wheeze in children. Eur Respir J. 2016;48(1):115-24.
Siu AL, US Preventive Services Task Force. Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: US Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015;163(8):622-34.
Turner E, Jones M, Vaz LR, Coleman T. Systematic Review and Meta-Analysis to Assess the Safety of Bupropion and Varenicline in Pregnancy. Nicotine Tob Res. 2019;21(8):1001-1010.
Baba S, Wikström AK, Stephansson O, Cnattingius S. Influence of snuff and smoking habits in early pregnancy on risks for stillbirth and early neonatal mortality. Nicotine Tob Res. 2014;16(1):78-83.
England LJ, Levine RJ, Mills JL, Klebanoff MA, Yu KF, Cnattingius S. Adverse pregnancy outcomes in snuff users. Am J Obstet Gynecol. 2003;189(4):939-43.
Gunnerbeck A, Wikström AK, Bonamy AK, Wickström R, Cnattingius S. Relationship of maternal snuff use and cigarette smoking with neonatal apnea. Pediatrics. 2011;128(3):503-9.
Pedersen L, Petronis KR, Nørgaard M, Mo J, Frøslev T, Stephansson O et al. Risk of adverse birth outcomes after maternal varenicline use: A population-based observational study in Denmark and Sweden. Pharmacoepidemiol Drug Saf. 2020;29(1):94-102.
Tran DT, Preen DB, Einarsdottir K, Kemp-Casey A, Randall D, Jorm LR et al. Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study. BMC Med. 2020;18(1):15.
Richardson JL, Stephens S, Yates LM, Diav-Citrin O, Arnon J, Beghin D et al. Pregnancy outcomes after maternal varenicline use; analysis of surveillance data collected by the European Network of Teratology Information Services. Reprod Toxicol. 2017;67(1):26-34.
- Kallen K. The impact of maternal smoking during pregnancy on delivery outcome. Eur J Public Health 2001;11:329-33.
- Abraham M, Alramadhan S, Iniguez C, Duijts L, Jaddoe VW, Den Dekker HT et al. A systematic review of maternal smoking during pregnancy and fetal measurements with meta-analysis. PLoS One. 2017;12(2):e0170946.
- Jaddoe VW, Verburg BO, de Ridder MA, Hofman A, Mackenbach JP, Moll HA et al. Maternal smoking and fetal growth characteristics in different periods of pregnancy: the generation R study. Am J Epidemiol. 2007;165(10):1207-15.
- Tatiana M Anderson, Juan M Lavista Ferres, Shirley You Ren, Rachel Y Moon, Richard D Goldstein, Jan-Marino Ramirez, Edwin A Mitchell. Maternal Smoking Before and During Pregnancy and the Risk of Sudden Unexpected Infant Death. Pediatrics. 2019;143(4):e20183325.
- Vardavas CI, Hohmann C, Patelarou E, Martinez D, Henderson AJ, Granell R et al. The independent role of prenatal and postnatal exposure to active and passive smoking on the development of early wheeze in children. Eur Respir J. 2016;48(1):115-24.
- Siu AL, US Preventive Services Task Force. Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: US Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015;163(8):622-34.
- Turner E, Jones M, Vaz LR, Coleman T. Systematic Review and Meta-Analysis to Assess the Safety of Bupropion and Varenicline in Pregnancy. Nicotine Tob Res. 2019;21(8):1001-1010.
- Baba S, Wikström AK, Stephansson O, Cnattingius S. Influence of snuff and smoking habits in early pregnancy on risks for stillbirth and early neonatal mortality. Nicotine Tob Res. 2014;16(1):78-83.
- England LJ, Levine RJ, Mills JL, Klebanoff MA, Yu KF, Cnattingius S. Adverse pregnancy outcomes in snuff users. Am J Obstet Gynecol. 2003;189(4):939-43.
- Gunnerbeck A, Wikström AK, Bonamy AK, Wickström R, Cnattingius S. Relationship of maternal snuff use and cigarette smoking with neonatal apnea. Pediatrics. 2011;128(3):503-9.
- Pedersen L, Petronis KR, Nørgaard M, Mo J, Frøslev T, Stephansson O et al. Risk of adverse birth outcomes after maternal varenicline use: A population-based observational study in Denmark and Sweden. Pharmacoepidemiol Drug Saf. 2020;29(1):94-102.
- Tran DT, Preen DB, Einarsdottir K, Kemp-Casey A, Randall D, Jorm LR et al. Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study. BMC Med. 2020;18(1):15.
- Richardson JL, Stephens S, Yates LM, Diav-Citrin O, Arnon J, Beghin D et al. Pregnancy outcomes after maternal varenicline use; analysis of surveillance data collected by the European Network of Teratology Information Services. Reprod Toxicol. 2017;67(1):26-34.